L-Tetrahydropalmatine
weak data3 sources
L-tetrahydropalmatine has more human data than most of this shelf, and the mechanism is well understood. The catch: it’s a dopamine antagonist, which makes it a sedative and analgesic, not a cognitive enhancer. The heroin-withdrawal trial is genuinely interesting, and the poisoning literature says nobody died in 37 cases, though 10.8% needed mechanical ventilation and intensive care. If you want focus, this is the wrong compound, and semax or noopept are better starting points for that. If you want calm backed by real pharmacology, it’s one of the few here with actual receipts.
What it is
L-tetrahydropalmatine, usually shortened to L-THP, is an isoquinoline alkaloid from Corydalis and Stephania plants, used in traditional Chinese medicine for centuries as a sedative and pain reliever. The pharmacology explains the old uses cleanly: it agonizes D1 dopamine receptors and antagonizes D2 receptors, a profile that produces sedation, analgesia, and reduced craving. It also blocks alpha4beta2 nicotinic acetylcholine receptors noncompetitively, which may be part of why it dulls stimulant reward.
This is not a nootropic in the usual sense. It sits on the cognition shelf because people looking for brain compounds will find it, and the honest answer is that it calms the brain rather than sharpening it. The clinical interest is in addiction and withdrawal, not focus.
What the research shows
The human data is real but small, pointed at addiction and pain rather than cognition:
Realistic protocols
People run L-THP for sleep, anxiety, and craving management. The dopamine-antagonist profile means the sedation is the mechanism itself. Dose-response is straightforward: more puts you down harder. Take it in the evening if you are using it for sleep. Stacking it with other sedatives or alcohol adds risk the poisoning data makes concrete.
Side effects
The dopamine-antagonist profile means the side effects are the mechanism turned up too loud: